‘Disease Doesn’t Respect Silos’: Sharpless Sets Flexibility As Priority

Acting US FDA Commissioner Ned Sharpless described his vision for an efficient, adaptable agency on 2 May at the Food & Drug Law Institute’s annual conference in Washington, DC.

FDA acting Commissioner Ned Sharpless speaking at FDLI 2019
FDA acting Commissioner Ned Sharpless at FDLI 2019 • Source: Ferdous Al-Faruque

More from Regulation

More from Policy & Regulation